Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Additionally, 698 CNPs showed significant differences with false discovery rate (FDR)<0.01 among the 10 populations and these loci overlap with known disease-associated or pharmacogenetic-related genes such as CFHR3 and CFHR1 (age related macular degeneration), GSTTI (metabolism of various carcinogenic compounds and cancers) and UGT2B17 (prostate cancer and graft-versus-host disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP334693.RABoiMOklFGAsVJADL-pqeZqkkbtCCaxUK87CM8-QvpKs130_assertion description "[Additionally, 698 CNPs showed significant differences with false discovery rate (FDR)<0.01 among the 10 populations and these loci overlap with known disease-associated or pharmacogenetic-related genes such as CFHR3 and CFHR1 (age related macular degeneration), GSTTI (metabolism of various carcinogenic compounds and cancers) and UGT2B17 (prostate cancer and graft-versus-host disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP334693.RABoiMOklFGAsVJADL-pqeZqkkbtCCaxUK87CM8-QvpKs130_provenance.
• NP924758.RAAwMJQoMRZ-Q_myIAR3e4BbkvRKqcQrVG0-Y3s7TVNmM130_assertion description "[Additionally, 698 CNPs showed significant differences with false discovery rate (FDR)<0.01 among the 10 populations and these loci overlap with known disease-associated or pharmacogenetic-related genes such as CFHR3 and CFHR1 (age related macular degeneration), GSTTI (metabolism of various carcinogenic compounds and cancers) and UGT2B17 (prostate cancer and graft-versus-host disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924758.RAAwMJQoMRZ-Q_myIAR3e4BbkvRKqcQrVG0-Y3s7TVNmM130_provenance.
• NP447577.RAfFu4zFQ8B9TAnPkzpaKhtSO5nVGdfIU4u8LRXc6STys130_assertion description "[Additionally, 698 CNPs showed significant differences with false discovery rate (FDR)<0.01 among the 10 populations and these loci overlap with known disease-associated or pharmacogenetic-related genes such as CFHR3 and CFHR1 (age related macular degeneration), GSTTI (metabolism of various carcinogenic compounds and cancers) and UGT2B17 (prostate cancer and graft-versus-host disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP447577.RAfFu4zFQ8B9TAnPkzpaKhtSO5nVGdfIU4u8LRXc6STys130_provenance.
• NP395013.RA8zdG8DyWnoc2n2DtbECy9dv8IkJA1Na1q0juTxjfTfM130_assertion description "[Additionally, 698 CNPs showed significant differences with false discovery rate (FDR)<0.01 among the 10 populations and these loci overlap with known disease-associated or pharmacogenetic-related genes such as CFHR3 and CFHR1 (age related macular degeneration), GSTTI (metabolism of various carcinogenic compounds and cancers) and UGT2B17 (prostate cancer and graft-versus-host disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP395013.RA8zdG8DyWnoc2n2DtbECy9dv8IkJA1Na1q0juTxjfTfM130_provenance.
• NP338676.RAphhFIGxYA3qyJDAaallfeb5ZEb-WTFEACrq7mUSX1ws130_assertion description "[Additionally, 698 CNPs showed significant differences with false discovery rate (FDR)<0.01 among the 10 populations and these loci overlap with known disease-associated or pharmacogenetic-related genes such as CFHR3 and CFHR1 (age related macular degeneration), GSTTI (metabolism of various carcinogenic compounds and cancers) and UGT2B17 (prostate cancer and graft-versus-host disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP338676.RAphhFIGxYA3qyJDAaallfeb5ZEb-WTFEACrq7mUSX1ws130_provenance.
• NP177703.RABvGl4K39DJCXSfO4UBXFb1-z0cZb9ef-51xYC26Y-c8130_assertion description "[Additionally, 698 CNPs showed significant differences with false discovery rate (FDR)<0.01 among the 10 populations and these loci overlap with known disease-associated or pharmacogenetic-related genes such as CFHR3 and CFHR1 (age related macular degeneration), GSTTI (metabolism of various carcinogenic compounds and cancers) and UGT2B17 (prostate cancer and graft-versus-host disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP177703.RABvGl4K39DJCXSfO4UBXFb1-z0cZb9ef-51xYC26Y-c8130_provenance.
• NP462356.RAj4SmRoEi-Ozcl-lu2sCtQuqkPo9DxkfoL6l8bavSMto130_assertion description "[Additionally, 698 CNPs showed significant differences with false discovery rate (FDR)<0.01 among the 10 populations and these loci overlap with known disease-associated or pharmacogenetic-related genes such as CFHR3 and CFHR1 (age related macular degeneration), GSTTI (metabolism of various carcinogenic compounds and cancers) and UGT2B17 (prostate cancer and graft-versus-host disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP462356.RAj4SmRoEi-Ozcl-lu2sCtQuqkPo9DxkfoL6l8bavSMto130_provenance.
• NP814596.RAgJTxhcJiWI8ZdvIxaLowXXuTl_1gIsvTFt5u0T9ynlE130_assertion description "[Additionally, 698 CNPs showed significant differences with false discovery rate (FDR)<0.01 among the 10 populations and these loci overlap with known disease-associated or pharmacogenetic-related genes such as CFHR3 and CFHR1 (age related macular degeneration), GSTTI (metabolism of various carcinogenic compounds and cancers) and UGT2B17 (prostate cancer and graft-versus-host disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814596.RAgJTxhcJiWI8ZdvIxaLowXXuTl_1gIsvTFt5u0T9ynlE130_provenance.
• NP919432.RAk18nKIKTniOXFeM1Qz8LT7y5aLxY8D0FQVExRinP3bQ130_assertion description "[Additionally, 698 CNPs showed significant differences with false discovery rate (FDR)<0.01 among the 10 populations and these loci overlap with known disease-associated or pharmacogenetic-related genes such as CFHR3 and CFHR1 (age related macular degeneration), GSTTI (metabolism of various carcinogenic compounds and cancers) and UGT2B17 (prostate cancer and graft-versus-host disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP919432.RAk18nKIKTniOXFeM1Qz8LT7y5aLxY8D0FQVExRinP3bQ130_provenance.
• NP204820.RAIQ0zw6qdOJrqUXEoPMwjMArNH4U-m6SYL3QdmWSH5MQ130_assertion description "[Additionally, 698 CNPs showed significant differences with false discovery rate (FDR)<0.01 among the 10 populations and these loci overlap with known disease-associated or pharmacogenetic-related genes such as CFHR3 and CFHR1 (age related macular degeneration), GSTTI (metabolism of various carcinogenic compounds and cancers) and UGT2B17 (prostate cancer and graft-versus-host disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP204820.RAIQ0zw6qdOJrqUXEoPMwjMArNH4U-m6SYL3QdmWSH5MQ130_provenance.
• NP430355.RARRH_UUOn1pCV6VoIUYdgG9nn5Xn6x7ymcQ7j_pFWElk130_assertion description "[Additionally, 698 CNPs showed significant differences with false discovery rate (FDR)<0.01 among the 10 populations and these loci overlap with known disease-associated or pharmacogenetic-related genes such as CFHR3 and CFHR1 (age related macular degeneration), GSTTI (metabolism of various carcinogenic compounds and cancers) and UGT2B17 (prostate cancer and graft-versus-host disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP430355.RARRH_UUOn1pCV6VoIUYdgG9nn5Xn6x7ymcQ7j_pFWElk130_provenance.
• NP791825.RAyFvXjtsKfTe-icDXSNkP6ZPW_5YVu566m1BcR5Wg4DA130_assertion description "[Additionally, 698 CNPs showed significant differences with false discovery rate (FDR)<0.01 among the 10 populations and these loci overlap with known disease-associated or pharmacogenetic-related genes such as CFHR3 and CFHR1 (age related macular degeneration), GSTTI (metabolism of various carcinogenic compounds and cancers) and UGT2B17 (prostate cancer and graft-versus-host disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP791825.RAyFvXjtsKfTe-icDXSNkP6ZPW_5YVu566m1BcR5Wg4DA130_provenance.
• NP842769.RA5C8vqH72SorKyaphVh0-EItrh1Fno_lTF6u_cYLGpX0130_assertion description "[Additionally, 698 CNPs showed significant differences with false discovery rate (FDR)<0.01 among the 10 populations and these loci overlap with known disease-associated or pharmacogenetic-related genes such as CFHR3 and CFHR1 (age related macular degeneration), GSTTI (metabolism of various carcinogenic compounds and cancers) and UGT2B17 (prostate cancer and graft-versus-host disease).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP842769.RA5C8vqH72SorKyaphVh0-EItrh1Fno_lTF6u_cYLGpX0130_provenance.